Haw Par Corp is looking to grow its revenues from the Indian market by over 135% in the next couple of years. The India unit, subsidiary of Haw Par Healthcare that's owned by Singapore Exchange-listed firm Haw Par Corp, will also launch one new product every year over the next two years. The idea, according to a top company executive, is to build India product portfolio that currently comprises of ointment brand Tiger Balm only. Sold globally in over 100 countries, Tiger Balm range is manufactured in India through a facility in Hyderabad. For its distribution across key markets across the country, Haw Par India has appointed Alkem Healthcare as its exclusive distributor for the Tiger Balm range of products including the newly launched 'Tiger Balm Neck and Shoulder Rub'.
Source: dna February 14, 2018 02:23 UTC